Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: -0.07 (-10.94%)
Spread: 0.10 (18.182%)
Open: 0.65
High: 0.57
Low: 0.57
Prev. Close: 0.64
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement on Convertible Loan Note Refinancing

27 Nov 2023 07:00

RNS Number : 6740U
Bushveld Minerals Limited
27 November 2023
 

Market Abuse Regulation ("MAR") Disclosure

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR. 

Bushveld Minerals Limited

("Bushveld" or the "Company")

 

Agreement on Convertible Loan Note Refinancing

 

27 November 2023

 

Bushveld Minerals Limited (AIM: BMN), the integrated primary vanadium producer, is pleased to announce that it has entered into a conditional agreement to refinance its existing convertible loan notes with Orion Mine Finance ("Orion"), following the Term Sheet agreed in May this year.

 

Highlights:

 

§ Today's conditional agreement extends the maturity date for Bushveld's existing convertible loan notes to 31 January 2024 (from 21 December 2023) and refinances the convertible debt obligations of c.US$46.9 million (including accrued interest) as follows:

· Conversion of 10% of the outstanding balance (including interest) of the convertible debt obligations ("CLN Balance"), expected to be c.US$4.7 million, as at the effective date[1] into shares at 3.00p per share.

· A new convertible loan note of c.US$14.1 million representing 30% of the CLN Balance maturing in June 2028.

· A term loan of c.US$28.1 million representing 60% of the CLN Balance.

· Supplemental royalty at not more than 0.264% of Bushveld's gross revenues and reducing by 80% at the term loan maturity.

 

§ New structure better aligns repayment with expected internal cash generation projections.

 

§ The refinancing is conditional upon (inter alia):

· Entry into the finance and security documents, which are progressing accordingly.

· Bushveld shareholder approval.

· Raising of at least US$12.0 million via the issue of new ordinary shares in the Company to third party and existing investors (which would be satisfied by the proposed equity investment by Southern Point Resources - Fund 1 SA L.P., represented by its general partner SPR GP1 Proprietary Limited).

· Consent by the Financial Surveillance Department of the South African Reserve Bank.

· Completion of the Share Exchange transaction between the Company and the minority shareholders in Bushveld Vametco Holdings Pty Ltd, by which the Company will become the 100% shareholder in Bushveld Vametco Holdings Pty Ltd, as announced on 30 October 2023.

 

§ All outstanding conditions are expected to be satisfied in due course, and the transaction is expected to complete before the 31 January 2024 deadline agreed by all parties.

 

 

 

Craig Coltman, CEO of Bushveld Minerals commented:

"I am pleased to announce today's agreement with Orion, which has supported the Company since it's initial investment three years ago. Since first announcing the terms of the proposed restructuring earlier this year, there has been an imperative to enter into a binding agreement with Orion, and whilst the refinancing remains conditional upon certain items, including Bushveld shareholders' approval, it provides certainty as we move forward with the other elements of our financial package.

The restructuring is a key part of our strategy to restore value in the Company, along with ensuring Bushveld delivers its operational targets, simplifies its corporate structure and refines its investment proposition."

 

 

Key Terms of the Proposed Refinancing

§ 10% of the CLN Balance (c. US$4.7 million) to be capitalised into a subscription for shares in Bushveld at 3.00p per share, a 48% premium to the 20-day weighted average share price (as at 24 November 2023).

 

§ 30% of the CLN Balance (c.US$14.1 million) to remain as a convertible loan note with the following revised terms ("New CLN"):

· Interest: 12%

· Conversion price: 3.99p

· Maturity Date: 30 June 2028

· Bushveld shall have a one-time right to redeem 50% (in whole and not in part) of the New CLN in June 2026, subject to the right of Orion to elect for conversion of the same for a 30-day period.

 

§ 60% of the CLN Balance (c.US$28.1 million) will be converted into a secured term loan ("Term Loan") on the following terms:

· Interest: 6.0% ("Margin") plus the greater of (i) 3-month Secured Overnight Financing Rate ("SOFR") and (ii) 3.0% per annum.

· Interest payable quarterly in arrears in cash starting from the last business day of the quarter in which the closing of the transaction occurs and on the last business day of each quarter thereafter. In the event that the Company has insufficient cash available to pay interest on its due date, the interest due on that date shall continue to accrue. In the event of default, the Margin will be increased by 3%.

 Principal repayments structured to

a. 25% of the facility amount (c. US$7.0 million) to be repaid by 30 June 2024

b. 30% of the facility amount (c. US$8.4 million) to be repaid by 30 June 2025

c. 45% of the facility amount (c. US$12.6 million) to be repaid by 30 June 2026

 

· The facility may be prepaid in whole or in part at any time. Prepayment is subject to the following early redemption fee schedule based on the outstanding balance at the time of prepayment.

Prior to 30 June 2024: 4%

After 30 June 2024 until 30 June 2025: 3%

After 30 June 2025 until 30 June 2026: 2% 

 

§ Supplemental royalty, on the same terms as the existing Production Financing Agreement during the tenure of the Term Loan, except for the following:

· Royalty repayment rate of 0.264% with a realised price per kgV of less than US$47/kgV.

· Royalty repayment rate of 0.216% with a realised price per kgV of greater than US$47/kgV.

· The later of 30 June 2027 and when the Term Loan has been fully repaid, the repayment rate will reduce by 80% and shall be payable for the life of the Vametco operation.

 

 

 

ENDS

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals Limited

+27 (0) 11 268 6555

Craig Coltman, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

 

Grant Baker / Richard Parlons

 

 

RBC Capital Markets

Joint Broker

+44 (0) 20 7653 4000

Jamil Miah / Sahil Suleman

 

 

Tavistock

Financial PR

Gareth Tredway / Tara Vivian-Neal/ James Whitaker

+44 (0) 207 920 3150

 

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a vertically integrated primary vanadium producer, it is one of only three operating primary vanadium producers. In 2022, the Company produced more than 3,800 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors.

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

 

 

 


[1] The date on which all conditions referred to below are satisfied.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDBBDBDDDDGXL
Date   Source Headline
6th Jan 20217:00 amRNSTotal Voting Rights
4th Jan 202111:34 amRNSHolding(s) in Company
18th Dec 20202:33 pmRNSPartial repayment of Duferco convertible loan note
30th Nov 20207:00 amRNSBushveld satisfies conditions of US$65m funding
27th Nov 20203:06 pmRNSGeneral meeting results
24th Nov 20207:00 amRNSQ3 and 9 months 2020 Operational Update
11th Nov 20207:00 amRNSVametco Mini-Grid Update
9th Nov 20207:01 amRNSCircular and Notice of GM
9th Nov 20207:00 amRNSSuccessful Raise of US$35M Convertible Loan Note
23rd Oct 202011:33 amRNSExchange Control Approval for Orion Transaction
19th Oct 20202:05 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:36 amRNSInterim Results for six months to end-June 2020
30th Sep 20207:13 amRNSFinancing with Orion and Convertible Loan Note
18th Sep 20202:37 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSVanadium Rental Partnership with Invinity
2nd Sep 20207:00 amRNSQ2 2020 and H1 2020 Operational Update
5th Aug 20203:18 pmRNSResult of AGM
3rd Aug 20207:00 amRNSInvestment in Enerox GmbH
21st Jul 202012:55 pmRNSDirector/PDMR Shareholding
30th Jun 202012:27 pmRNSPosting of accounts and notice of general meeting
23rd Jun 20208:58 amRNSFinal Results for the Year Ended 31 December 2019
14th May 202011:05 amRNSSecond Price Monitoring Extn
14th May 202011:00 amRNSPrice Monitoring Extension
11th May 20202:05 pmRNSSecond Price Monitoring Extn
11th May 20202:00 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSQ1 2020 Operational Update
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
14th Apr 202011:05 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
7th Apr 202011:05 amRNSSecond Price Monitoring Extn
7th Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20203:51 pmRNSBushveld to hold 8.71% of newly created Invinity
24th Mar 20209:12 amRNSCovid-19 Update and Operation Halt
23rd Mar 202011:05 amRNSSecond Price Monitoring Extn
23rd Mar 202011:00 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSDirectorate Change
12th Mar 20202:06 pmRNSSecond Price Monitoring Extn
12th Mar 20202:00 pmRNSPrice Monitoring Extension
9th Mar 20204:41 pmRNSSecond Price Monitoring Extn
9th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSJoint Venture agreement with redT
30th Jan 20209:17 amRNSFull Year 2019 and Q4 2019 Operational Update
19th Dec 20193:02 pmRNSUpdate on investment in Enerox GmbH ("Enerox")
12th Nov 20194:32 pmRNSPotential investment in Enerox GmbH
7th Nov 20197:01 amRNSBushveld Minerals Q3 2019 Operational Update
7th Nov 20197:00 amRNSVanchem Acquisition Completed
1st Nov 20199:46 amRNSStrategy for partnering with VRFB companies
1st Nov 20199:45 amRNSSupport for redT - Avalon Merger

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.